Eton Pharmaceuticals Ownership | Who Owns Eton Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Eton Pharmaceuticals Ownership Summary


Eton Pharmaceuticals is owned by 61.49% institutional investors, 4.39% insiders, and 34.12% retail investors. Opaleye management is the largest institutional shareholder, holding 11.01% of ETON shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.56% of its assets in Eton Pharmaceuticals shares.

ETON Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEton Pharmaceuticals61.49%4.39%34.12%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Opaleye management2.85M11.01%$37.99M
Ecor1 capital1.83M7.06%$24.37M
Blackrock funding, inc. /de1.53M5.70%$21.83M
Nantahala capital management1.18M4.37%$16.76M
Vanguard group1.06M4.11%$14.17M
Divisadero street capital management, lp497.72K1.85%$7.09M
Westside investment management472.79K1.76%$6.74M
Acadian asset management392.71K1.46%$5.59M
Cannell capital388.18K1.44%$5.53M
Blackrock282.39K1.10%$929.06K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Opaleye management2.85M6.65%$37.99M
Cannell capital388.18K1.65%$5.53M
Westside investment management472.79K1.25%$6.74M
Ecor1 capital1.83M0.92%$24.37M
Nantahala capital management1.18M0.66%$16.76M
Diametric capital, lp84.86K0.65%$1.21M
Apis capital advisors106.00K0.54%$1.51M
Aristides capital167.59K0.47%$2.39M
Divisadero street capital management, lp497.72K0.45%$7.09M
Soleus capital management285.00K0.27%$4.06M

Top Buyers

HolderShares% AssetsChange
Ecor1 capital1.83M0.92%1.26M
Blackrock funding, inc. /de1.53M0.00%1.19M
Divisadero street capital management, lp497.72K0.45%497.72K
Soleus capital management285.00K0.27%285.00K
Millennium management138.89K0.00%138.89K

Top Sellers

HolderShares% AssetsChange
Cannell capital388.18K1.65%-303.19K
Parkman healthcare partners---276.89K
Wasatch advisors lp---231.33K
Paradigm capital management inc/ny---200.00K
Acuitas investments---185.82K

New Positions

HolderShares% AssetsChangeValue
Divisadero street capital management, lp497.72K0.45%497.72K$7.09M
Soleus capital management285.00K0.27%285.00K$4.06M
Millennium management138.89K0.00%138.89K$1.85M
Apis capital advisors106.00K0.54%106.00K$1.51M
Anchor capital advisors60.43K0.02%60.43K$804.95K

Sold Out

HolderChange
Lindbrook capital-4.00
Advisor group-260.00
Group one trading-634.00
Federated hermes-686.00
Plante moran financial advisors-1.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202586-1.15%16,537,10735.73%612.99%6115.09%17-26.09%
Mar 31, 20258920.27%14,123,1147.52%522.04%531.92%2471.43%
Dec 31, 202424-52.94%3,267,082-65.64%120.94%14-46.15%6-
Sep 30, 2024518.51%9,507,91415.55%363.60%2685.71%6-60.00%
Jun 30, 2024474.44%8,228,30814.56%314.09%14-1515.38%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv686.28K2.56%-15.23K
Vanguard US Total Market Shares ETF681.72K2.54%-
iShares Russell 2000 ETF611.88K2.28%-11.65K
Vanguard Institutional Extnd Mkt Idx Tr275.36K1.03%-119.33K
iShares Russell 2000 Growth ETF222.68K0.83%-
Paradigm Micro-Cap200.00K0.77%-
Fidelity Extended Market Index138.62K0.52%-362.00
Vanguard Russell 2000 ETF122.35K0.46%-8.18K
Wasatch Micro Cap Value105.10K0.40%-
Bridgeway Ultra-Small Company106.07K0.40%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 20, 2025Gruber James R. Chief Financial OfficerSell$42.15K
Aug 19, 2025Gruber James R. Chief Financial OfficerSell$631.57K
Jun 12, 2025Krempa David Chief Business OfficerSell$253.30K
Jun 13, 2025Krempa David Chief Business OfficerSell$100.44K
Jun 16, 2025Krempa David Chief Business OfficerSell$150.58K

Insider Transactions Trends


DateBuySell
2025 Q3-2
2025 Q228
2025 Q1--
2024 Q47-
2024 Q34-

ETON Ownership FAQ


Who Owns Eton Pharmaceuticals?

Eton Pharmaceuticals shareholders are primarily institutional investors at 61.49%, followed by 4.39% insiders and 34.12% retail investors. The average institutional ownership in Eton Pharmaceuticals's industry, Biotech Stocks , is 306.59%, which Eton Pharmaceuticals falls below.

Who owns the most shares of Eton Pharmaceuticals?

Eton Pharmaceuticals’s largest shareholders are Opaleye management (2.85M shares, 11.01%), Ecor1 capital (1.83M shares, 7.06%), and Blackrock funding, inc. /de (1.53M shares, 5.70%). Together, they hold 23.77% of Eton Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eton Pharmaceuticals?

Yes, BlackRock owns 1.10% of Eton Pharmaceuticals, totaling 282.39K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 929.06K$. In the last quarter, BlackRock decreased its holdings by -563 shares, a -0.20% change.

Who is Eton Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Opaleye management is Eton Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 6.65% of its assets in 2.85M Eton Pharmaceuticals shares, valued at 37.99M$.

Who is the top mutual fund holder of Eton Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eton Pharmaceuticals shares, with 2.56% of its total shares outstanding invested in 686.28K Eton Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools